Table 2 Treatment-related adverse events
Grades 1–2 | Grades 3–5 | |
|---|---|---|
Neutropaenia | 16 (32.0%) | 10 (20.0%) |
Anaemia | 14 (28.0%) | 4 (8.0%) |
Rash | 16 (32.0%) | 0 |
Hepatic dysfunction | 10 (20.0%) | 2 (4.0%) |
Thrombocytopaenia | 7 (14.0%) | 4 (8.0%) |
Nausea | 13 (26.0%) | 0 |
Pulmonary infection | 3 (6.0%) | 2 (4.0%) |
Renal dysfunction | 4 (8.0%) | 1 (2.0%) |
Thyroid dysfunction | 1 (2.0%) | 0 |
Pulmonary embolism | 0 | 1 (2.0%) |
Fever | 2 (4.0%) | 1 (1.0%) |
Febrile neutropaenia | 0 | 1 (2.0%) |
Haemoptysis | 2 (4.0%) | 1 (2.0%) |
Atrial fibrillation | 2 (4.0%) | 0 |
Paresthaesia | 2 (4.0%) | 0 |
Hiccup | 1 (2.0%) | 0 |
Diarrhoea | 1 (2.0%) | 0 |